Technical Support
(877) SEPAX-US, press 3

Representative Literature References

View all
Year Product Sample Title
2016Zenix-C SEC-150InsulinContribution of TyrB26 to the Function and Stability of Insulin. Structure-activity relationships at a conserved hormone-receptor interface
Journal of Biological Chemistry, April 26, 2016, M115.708347.
2016Zenix-C SEC-300ADC, Fusion ProteinTargeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free-Protein Synthesis
Mol Cancer Ther. 2016 Jun;15(6):1291-300. doi: 10.1158/1535-7163
2015Zenix-C SEC-300AntibodyIntrinsic fluorescence-based at situ soft sensor for monitoring monoclonal antibody aggregation
Biotechnology Progress
2017Zenix-C SEC-300AntibodyEfficient generation of single domain antibodies with high affinities and enhanced thermal stabilities
Scientific Reports 7, Article number: 5794 (2017) doi:10.1038/s41598-017-06277-x
2016Zenix-C SEC-300AntibodyPlant-based technologies to enable rapid response to Ebola outbreak
Engineering Conferences International, Vaccine Technology VI Proceedings
2018Zenix-C SEC-300AntibodyA bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases
The Journal of Biological Chemistry 293, 9326-9334. 10.1074/jbc.M117.818559
2015Zenix-C SEC-300Antibody, IgEA single glycan on IgE is indispensable for initiation of anaphylaxis
J. Exp. Med. 2015 Vol. 212 No. 4 457–467
2017Zenix-C SEC-300Fusion ProteinImprovement of Pharmacokinetic Profle of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
Sci Rep. 2017 Aug 21;7(1):8953. doi: 10.1038/s41598-017-09518-1.
2016Zenix-C SEC-300PeptideGenetic fusion of human FGF21 to a synthetic polypeptide improves pharmacokinetics and pharmacodynamics in a mouse model of obesity
Br J Pharmacol. 2016 Jul;173(14):2208-23. doi: 10.1111/bph.13499.
2015Zenix-C SEC-300ProteinImpact of pH on molecular structure and surface properties of lentillegumin-like protein and its application as foam stabilizer
Colloids and Surfaces B: Biointerfaces 132 (2015) 45–53
2015Zenix-C SEC-300ProteinCharacterization and quantification of histidine degradation in therapeutic protein formulations by size exclusion-hydrophilic interaction two dimensional-liquid chromatography with stable-isotope labeling mass spectrometry
Journal of Chromatography A Volume 1426, 24 December 2015, Pages 133–139
2015Zenix-C SEC-300ProteinAutomated two-step chromatography using an ÄKTA equipped with in-line dilution capability
Journal of Chromatography A Volume 1424, 11 December 2015, Pages 51–58
2016Zenix-C SEC-300Protein, DNA/RNAPharmacokinetic and Pharmacodynamic Investigations of ION-353382, a Model Antisense Oligonucleotide: Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice
Nucleic Acid Therapeutics, March 31, 2016
2016Zenix-C SEC-80Polymeric SubstancesDevelopment of a Simple Nonbiological Method for Converting Lignin-Derived Aromatics into Nonaromatic Polymeric Substances with Fluorescent Activity
ACS Sustainable Chem. Eng., 2016, 4 (8), pp 4411–4416 DOI: 10.1021/acssuschemeng.6b01009

© 2019 Sepax Technologies, Inc. All Rights Reserved.